Furthermore, increased VIP and VIP receptor 2 (VPAC2) levels in newborns are associated with an increased chance of developing autism spectrum disorder (ASD) [54,55,56], further supporting the role of VIP in neurodevelopment. This evidence concerns the gene VIP and autism spectrum disorder.